These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35137898)

  • 1. Population pharmacokinetic modeling of benznidazole in Brazilian patients with chronic Chagas disease.
    Frade VP; Moreira CHV; Sabino EC; Bedor DCG; Ghilard FR; Oliveira CDL; Sanches C
    Rev Inst Med Trop Sao Paulo; 2022; 64():e4. PubMed ID: 35137898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of Benznidazole in Experimental Chronic Chagas Disease Using the Swiss Mouse-Berenice-78 Trypanosoma cruzi Strain Model.
    de Jesus SM; Pinto L; Moreira FL; Nardotto GHB; Cristofoletti R; Perin L; Fonseca KDS; Barbêdo P; Bandeira LC; Vieira PMA; Carneiro CM
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33168611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetic study of benznidazole in pediatric Chagas disease suggests efficacy despite lower plasma concentrations than in adults.
    Altcheh J; Moscatelli G; Mastrantonio G; Moroni S; Giglio N; Marson ME; Ballering G; Bisio M; Koren G; García-Bournissen F
    PLoS Negl Trop Dis; 2014 May; 8(5):e2907. PubMed ID: 24853169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of benznidazole in adult patients with Chagas disease.
    Soy D; Aldasoro E; Guerrero L; Posada E; Serret N; Mejía T; Urbina JA; Gascón J
    Antimicrob Agents Chemother; 2015; 59(6):3342-9. PubMed ID: 25824212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial.
    Morillo CA; Waskin H; Sosa-Estani S; Del Carmen Bangher M; Cuneo C; Milesi R; Mallagray M; Apt W; Beloscar J; Gascon J; Molina I; Echeverria LE; Colombo H; Perez-Molina JA; Wyss F; Meeks B; Bonilla LR; Gao P; Wei B; McCarthy M; Yusuf S;
    J Am Coll Cardiol; 2017 Feb; 69(8):939-947. PubMed ID: 28231946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on benznidazole for the treatment of patients with Chagas disease.
    Thakare R; Dasgupta A; Chopra S
    Drugs Today (Barc); 2018 Jan; 54(1):15-23. PubMed ID: 29569658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the toxicity of two treatment schemes with benznidazole for chronic Chagas disease: a prospective cohort study in two Spanish referral centres.
    Crespillo-Andújar C; López-Vélez R; Trigo E; Norman F; Díaz-Menéndez M; Monge-Maillo B; Arsuaga M; Pérez-Molina JA
    Clin Microbiol Infect; 2020 Mar; 26(3):384.e1-384.e4. PubMed ID: 31740423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of posaconazole and benznidazole for chronic Chagas' disease.
    Molina I; Gómez i Prat J; Salvador F; Treviño B; Sulleiro E; Serre N; Pou D; Roure S; Cabezos J; Valerio L; Blanco-Grau A; Sánchez-Montalvá A; Vidal X; Pahissa A
    N Engl J Med; 2014 May; 370(20):1899-908. PubMed ID: 24827034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Chagas disease with advanced cardiac complications in Japan: Case report and literature review.
    Imai K; Maeda T; Sayama Y; Osa M; Mikita K; Kurane I; Miyahira Y; Kawana A; Miura S
    Parasitol Int; 2015 Oct; 64(5):240-2. PubMed ID: 25744336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should benznidazole be used in chronic Chagas' disease?
    Bestetti RB
    Lancet; 1997 Mar; 349(9052):653. PubMed ID: 9057760
    [No Abstract]   [Full Text] [Related]  

  • 11. [Benznidazole and chronic Chagas disease].
    Manigot DA
    Medicina (B Aires); 1984; 44(1):105-6. PubMed ID: 6443011
    [No Abstract]   [Full Text] [Related]  

  • 12. Tolerance of benznidazole in treatment of Chagas' disease in adults.
    Pinazo MJ; Muñoz J; Posada E; López-Chejade P; Gállego M; Ayala E; del Cacho E; Soy D; Gascon J
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4896-9. PubMed ID: 20823286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of benznidazole as a Chagas disease therapeutic.
    Caldas IS; Santos EG; Novaes RD
    Expert Opin Pharmacother; 2019 Oct; 20(15):1797-1807. PubMed ID: 31456439
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of the undetermined form of Chagas disease with nifortimox and benzonidazole].
    Ferreira Hde O
    Rev Soc Bras Med Trop; 1990; 23(4):209-11. PubMed ID: 2133586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the immune response after treatment with benznidazole versus no treatment in patients with chronic indeterminate Chagas disease.
    Vallejo A; Monge-Maillo B; Gutiérrez C; Norman FF; López-Vélez R; Pérez-Molina JA
    Acta Trop; 2016 Dec; 164():117-124. PubMed ID: 27619190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference of effective antitrypanosomal dosages of benznidazole in mice and man. Chemotherapeutic and pharmacokinetic results.
    Richle RW; Raaflaub J
    Acta Trop; 1980 Sep; 37(3):257-61. PubMed ID: 6106364
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial.
    Viotti R; Vigliano C; Lococo B; Bertocchi G; Petti M; Alvarez MG; Postan M; Armenti A
    Ann Intern Med; 2006 May; 144(10):724-34. PubMed ID: 16702588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas' disease: a prospective study in a non-disease-endemic country.
    Murcia L; Carrilero B; Muñoz MJ; Iborra MA; Segovia M
    J Antimicrob Chemother; 2010 Aug; 65(8):1759-64. PubMed ID: 20542903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and serological evolution in chronic Chagas disease patients in a 4-year pharmacotherapy follow-up: a preliminary study.
    Andrade MC; Oliveira Mde F; Nagao-Dias AT; Coêlho IC; Cândido Dda S; Freitas EC; Coelho HL; Bezerra FS
    Rev Soc Bras Med Trop; 2013; 46(6):776-8. PubMed ID: 24474023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric clinical pharmacology studies in Chagas disease: focus on Argentina.
    Garcia-Bournissen F; Altcheh J; Giglio N; Mastrantonio G; Della Védova CO; Koren G
    Paediatr Drugs; 2009; 11(1):33-7. PubMed ID: 19127950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.